ICON PLCICLREarnings & Financial Report
Nasdaq · Industrials · Services-Commercial Physical & Biological Research
ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.
Revenue
$2.0B
Gross Profit
N/A
Operating Profit
$209.5M
Net Profit
$115.6M
Gross Margin
N/A
Operating Margin
10.4%
Net Margin
5.7%
YoY Growth
4.4%
EPS
$1.40
ICON PLC Q2 FY2023 Financial Summary
ICON PLC reported revenue of $2.0B (up 4.4% YoY) for Q2 FY2023, with a net profit of $115.6M (down 0.1% YoY) (5.7% margin).
Key Financial Metrics
| Total Revenue | $2.0B |
|---|---|
| Net Profit | $115.6M |
| Gross Margin | N/A |
| Operating Margin | 10.4% |
| Report Period | Q2 FY2023 |
ICON PLC Quarterly Revenue & Net Profit History
ICON PLC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $2.0B | +0.6% | $2.4M | 0.1% |
| Q2 FY2025 | $2.0B | -4.8% | $183.0M | 9.1% |
| Q1 FY2025 | $2.0B | -4.3% | $154.2M | 7.7% |
| Q3 FY2024 | $2.0B | -1.2% | $197.1M | 9.7% |
| Q2 FY2024 | $2.1B | +4.9% | $146.9M | 6.9% |
| Q1 FY2024 | $2.1B | +5.7% | $187.4M | 9.0% |
| Q3 FY2023 | $2.1B | +5.8% | $163.7M | 8.0% |
| Q2 FY2023 | $2.0B | +4.4% | $115.6M | 5.7% |
Income Statement
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.02B | $2.06B | $2.09B | $2.12B | $2.03B | $2.00B | $2.02B | $2.04B |
| YoY Growth | 4.4% | 5.8% | 5.7% | 4.9% | -1.2% | -4.3% | -4.8% | 0.6% |
Balance Sheet
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $17.11B | $17.03B | $17.05B | $16.97B | $17.21B | $16.72B | $16.60B | $16.51B |
| Liabilities | $8.31B | $8.07B | $7.62B | $7.38B | $7.44B | $7.22B | $7.05B | $7.17B |
| Equity | $8.80B | $8.96B | $9.43B | $9.59B | $9.77B | $9.50B | $9.56B | $9.33B |
Cash Flow
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $203.9M | $341.5M | $327.1M | $218.6M | $402.7M | $268.2M | $146.2M | $387.6M |